Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients

スポンサーリンク

概要

• 論文の詳細を見る
• 2002-05-01

著者

• Ohno Tomoyoshi

  社会保険中京病院 消化器科

• Toyama Tetsuya

  Department Of Gastroenterology And Hepatology Osaka University

• Takehara Tetsuo

  京都府立医科大学 消化器内科学

• Itoh Yoshito

  愛生会山科病院 内科

• Murakami Masato

  Department Of Radiology Ehime Prefectural Central Hospital

• Itoh Y

  Molecular Gastroenterology And Hepatology Kyoto Prefectural University Of Medicine Graduate School O

• Itoh Yoshito

  Molecular Gastroenterology And Hepatology Graduate School Of Medical Science Kyoto Prefectural Unive

• Itoh Yoshito

  Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine

• Okanoue Takeshi

  Center Of Gastroenterology And Hepatology Saiseikai Suita Hospital

• MORITA Atsuhiro

  Third Department of Internal Medicine, Kyoto Prefectural University of Medicine

• TOYAMA Tetsuya

  Third Department of Internal Medicine, Kyoto Prefectural University of Medicine

• KIRISHIMA Toshihiko

  Third Department of Internal Medicine, Kyoto Prefectural University of Medicine

• OKANOUE Takeshi

  Third Department of Internal Medicine, Kyoto Prefectural University of Medicine

• Mizokami M

  Department Of Virology And Liver Unit Nagoya City University Graduate School Of Medical Sciences

• Okanoue Takeshi

  Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine

• Itoh Yoshito

  Department Of Molecular Therapeutics Osaka University Graduate School Of Medicine

• Toyama T

  Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine

• Morita Atsuhiro

  Department Of Internal Medicine Aiseikai Yamashina Hospital

• Mizuno Masayuki

  Departments Of Gastroenterology And Hepatology Saiseikai Suita Hospital

• Nakajima Tomoki

  Saiseikai Kyoto Hospital

• DAIMON Yukiko

  Third Department of Internal Medicine, Kyoto Prefectural University of Medicine

• Daimon Yukiko

  Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine

• Nakashima Toshiaki

  Molecular Gastroenterology And Hepatology Kyoto Prefectural University Of Medicine Graduate School O

• NAKAJIMA Tomoki

  Second Department of Internal Medicine, Kyoto Prefectural Yosanoumi Hospital

• MINAMI Masahito

  Second Department of Internal Medicine, Kyoto Prefectural Yosanoumi Hospital

• Kirishima Toshihiko

  Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine

• Okada Toshihide

  Department Of Internal Medicine Graduate School Of Medicine Kanazawa University

• Okanoue Takeshi

  Third Department Of Internal Medicine Kyoto Prefectural Unicersity Of Medicine

• Nishimura Takeshi

  Molecular Gastroenterology And Hepatology Kyoto Prefectural University Of Medicine Graduate School O

関連論文

• Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma
• Relapse of hepatitis C in a pegylated-interferon-α-2b plus ribavirin-treated sustained virological responder
• Case-control study for the identification of virological factors associated with fulminant hepatitis B
• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
• A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
• Timing of interferon therapy and sources of infection in patients with acute hepatitis C
• Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma : two case reports
• Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
• Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
• Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
• Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
• Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
• Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
• Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
• Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
• Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
• Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection
• Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
• The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
• Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
• Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
• Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
• A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
• Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease
• Association of p53 Codon Arg72Pro and p73 G4C14-to-A4T14 at Exon 2 Genetic Polymorphisms with the Risk of Japanese Breast Cancer
• Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus
• β-Catenin Accumulation and Mutation of Exon 3 of the β-Catenin Gene in Hepatocellular Carcinoma
• Transforming Growth Factor B1 T29C Polymorphism and Breast Cancer Risk in Japanese Women
• Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
• Combination of Subareolar Blue Dye and Peritumoral RI for Sentinel Lymph Node Biopsy
• Limited association between a catechol-O-methyltransferase (CONT) polymorphism and breast cancer risk in Japan
• GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan
• Restoration of gut motility in Kit-deficient mice by bone marrow transplantation
• Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients
• Two subtypes (subgenotypes) of hepatitis B virus genotype C : A novel subtyping assay based on restriction fragment length polymorphism
• Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
• Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis
• Activated Kupffer cells play an important role in intra-hepatic Th1-associated necro-inflammation in Concanavalin A-induced hepatic injury in mice
• Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis
• Impaired cytotoxic T lymphocyte inductivity by dendritic cells derived from patients with hepatitis C virus-positive hepatocellular carcinoma
• Accidental exposure to HCV antibody-positive blood in hospital and pre-emptive one-shot interferon alpha-2b treatment
• A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load
• Styrene Maleic Acid Neocarzinostain-Transcatheter Arterial Embolization for Hepatocellular Carcinoma
• Spontaneous Cure of Chronic Hepatitis B with Hapatocellular Carcinoma and Concomitant HBsAg Reappearance and Disappearance
• Acute GB virus C/hepatitis G virus hepatitis preceding aplastic anemia
• Familial clustering of GB virus C/hepatitis G virus infection among the Jewish population in Uzbekistan
• Hepatitis B virus genotype G is an extremely rare genotype in Japan
• Ischemic hepatitis induced by mesenteric volvulus in a patient with chronic obstructive lung disease
• Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography : comparison with CT, power Doppler sonography, and dynamic MRI
• Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis : A pilot study
• Elevation of serum thioredoxin levels in patients with nonalcoholic steatohepatitis
• Prevalence and risk factors of hepatitis C virus infection among Koreans in rural area of Korea
• Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection
• Spontaneous regression of hepatocellular carcinoma : two case reports and a literature review
• Regression of esophageal papillomatous polyposis caused by high-risk type human papilloma virus
• Fluctuation of Serum HCV RNA Level during 12 Months in Individuals with Chronic Hepatitis C Virus Infection Who Had a Normal or Abnormal Serum ALT Level
• Primary hepatic marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type : case report and review of the literature
• A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan
• Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection
• Activation of B-Myb by E2F1 in hepatocellular carcinoma
• Genetic background of Japanese patients with adult-onset storage diseases in the liver
• Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C
• Non-prescription supplement-induced hepatitis with hyperferritinemia and mutation (H63D) in the HFE gene
• Role of hepatic iron in non-alcoholic steatohepatitis
• First phase viral kinetic parameters and prediction of response to interferon alpha-2b/ribavirin combination therapy in patients with chronic hepatitis C
• IB-11 Diagnostic findings of the liver histology in acute type of autoimmune hepatitis(THE 46TH ANNUAL MEETING OF THE JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY)
• Retreatment with interferon-α at dosages or period increased by 1.3 times is effective for treatment for transient responders and non-responders in chronic hepatitis C patients
• Evaluation of therapeutic effects on rectal varices using percutaneous color Doppler ultrasonography
• Endoscopic ultrasonographic evaluation of hemodynamics related to variceal relapse in esophageal variceal patients
• Clinical and endoscopic features of gastric varices secondary to splenic vein occlusion
• Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients
• Acute Liver Damage with Characteristic Apoptotic Hepatocytes by Ingestion of Aplysia kurodai, a Sea Hare
• Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus
• Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease
• Stimulated Kupffer cells attract cytotoxic T lymphocytes (CTL) and increase the adhesion of CTL to sinusoidal endothelial cells
• Management of hepatitis C ; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
• Novel single nucleotide polymorphisms of the cytokeratin 19 pseudogene are associated with primary biliary cirrhosis
• Clinical experience with newer electronic radial-type endoscopic color Doppler ultrasonography in the diagnosis of esophageal varices
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
• STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo
• Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders
• Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet
• Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
• Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
• Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma
• Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
• A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
• Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients
• The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
• Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease : Comparison with telomere-specific quantitative FISH and p21 immunohistochemistry
• Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
• Differential alteration of CD56^ and CD56^ natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
• Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
• Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study
• Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
• Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
• Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
• Greater age and hepatocellular aging are independent risk factors for hepatocellular carcinoma arising from non-B non-C non-alcoholic chronic liver disease

もっと見る 閉じる

スポンサーリンク